About
Auto-injector Trainers
Areas of Focus
Categories
Drug Delivery DeviceSoutheastern U.S.
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
9
As Collaborator
2
Total Enrollment
403
By Phase
NA: 9PHASE3: 1
By Status
COMPLETED: 9TERMINATED: 1UNKNOWN: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05829850Collaborator
An Effectiveness and Safety 6 Months Study of 3 Injections One Week Apart of SYNOLIS VA 40/80 in the Treatment of Symptomatic Knee Osteoarthritis
NACompleted
51 participants
Started: Dec 29, 2021 · Completed: Jan 9, 2023
NCT04952519Lead Sponsor
Efficacy of Amantadine Treatment in COVID-19 Patients
PHASE3Terminated
193 participants
Started: Mar 30, 2021 · Completed: Mar 10, 2022
NCT05829798Collaborator
An Efficacy and Safety 6-months Study of SYNOLIS VA 80/160 and SYNOLIS VA 40/80 in the Treatment of Symptomatic Knee Osteoarthritis
NACompleted
82 participants
Started: Jan 14, 2021 · Completed: Oct 1, 2021
NCT03715543Lead Sponsor
Surgical Resection of the Greater Splanchnic Nerve in Subjects Having Heart Failure With Preserved Ejection Fraction
NACompleted
8 participants
Started: Aug 1, 2016 · Completed: Jun 30, 2019
NCT02099851Lead Sponsor
Endovascular Carotid Body Ablation in Patients With Treatment- Resistant Hypertension: A Safety and Feasibility Study
NAUnknown
6 participants
Started: Mar 31, 2014
Funding History (1)
D
May 12, 2021
Locations (1)
Headquarters
Orlando, FL, United States
Map
Loading map...